![David W. Martin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David W. Martin
Oprichter bij
AvidBiotics Corp.
Profiel
David W.
Martin was the founder and the Chief Executive Officer & Director of AvidBiotics Corp., founded in 2005, and the President & Chief Executive Officer of EOS Biotechnology, Inc., founded in 1997.
Dr. Martin is also the founder of Pylum Biosciences, Inc., Xyphos Biosciences, Inc...
Dr. Martin's former job(s) include being the President & Chief Executive Officer of Lynx Therapeutics, Inc. from 1995 to 1996, the Chairman & Chief Executive Officer of GangaGen, Inc. in 2004, and a Director at Cubist Pharmaceuticals LLC from 1997 to 2009.
Dr. Martin's education history includes a doctorate degree from Duke University.
Actieve functies van David W. Martin
| Bedrijven | Functie | Begin |
|---|---|---|
AvidBiotics Corp.
 AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology Develops non-antibody proteins as targeted therapeutics against bacteria, viral infections and cancer | Oprichter | 01-01-2005 |
Pylum Biosciences, Inc.
 Pylum Biosciences, Inc. BiotechnologyHealth Technology Develops avidocin platform technology capable of generating bactericidal protein complexes | Oprichter | - |
Xyphos Biosciences, Inc.
 Xyphos Biosciences, Inc. BiotechnologyHealth Technology Engages in biotechnology business | Oprichter | - |
Eerdere bekende functies van David W. Martin
| Bedrijven | Functie | Einde |
|---|---|---|
| CUBIST PHARMACEUTICALS INC | Directeur/Bestuurslid | 04-06-2009 |
GangaGen, Inc.
 GangaGen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel antibacterial proteins targeting infectious diseases | Algemeen Directeur | 01-01-2004 |
EOS Biotechnology, Inc.
 EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Algemeen Directeur | 01-04-2003 |
Lynx Therapeutics, Inc.
 Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | President | 01-01-1996 |
Chiron Therapeutics, Inc. | President | 01-01-1995 |
Opleiding van David W. Martin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
77
Eerstegraads connecties
16
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 16 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Varian Medical Systems, Inc.
 Varian Medical Systems, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and supplies radiotherapy medical devices for treating cancer & develops related software solutions | Health Technology |
GangaGen, Inc.
GangaGen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel antibacterial proteins targeting infectious diseases | Health Technology |
AvidBiotics Corp.
AvidBiotics Corp. Pharmaceuticals: MajorHealth Technology Develops non-antibody proteins as targeted therapeutics against bacteria, viral infections and cancer | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Health Technology |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs | Health Technology |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Hastings
 University of California, Hastings Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chiron Therapeutics, Inc. | |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pylum Biosciences, Inc.
Pylum Biosciences, Inc. BiotechnologyHealth Technology Develops avidocin platform technology capable of generating bactericidal protein complexes | Health Technology |
Xyphos Biosciences, Inc.
Xyphos Biosciences, Inc. BiotechnologyHealth Technology Engages in biotechnology business | Health Technology |
